Microbicides Development Programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention
Open Access
- 27 October 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Trials
- Vol. 10 (1), 99
- https://doi.org/10.1186/1745-6215-10-99
Abstract
With 2.5 million new HIV infections per year, effective preventive methods against HIV are urgently needed, especially in sub-Saharan Africa. MDP301 is an ongoing trial of the vaginal microbicide PRO 2000/5 being conducted by the Microbicides Development Programme. The main objective of the trial is to determine the efficacy and safety of 0.5% and 2% concentrations of PRO 2000/5 gel compared to placebo in preventing vaginally acquired HIV infection. MDP301 is a multicentre randomised placebo-controlled Phase III trial. The design was informed by pre-trial feasibility and pilot studies. The choice of trial population, assessments and endpoints are discussed along with statistical and ethical considerations. Adaptations to the design were made during the conduct of the trial; these included closing a study arm and changing the timing of the primary endpoint. The development of effective microbicide products remains one of the strongest hopes for new biomedical prevention tools. MDP301 is the largest Phase III microbicide trial to date, with 9404 enrolments, and is scheduled for completion in September 2009. Results are expected towards the end of 2009. Current controlled trials ISRCTN64716212.Keywords
This publication has 11 references indexed in Scilit:
- Effectiveness of Cellulose Sulfate Vaginal Gel for the Prevention of HIV Infection: Results of a Phase III Trial in NigeriaPLOS ONE, 2008
- Lack of Effectiveness of Cellulose Sulfate Gel for the Prevention of Vaginal HIV TransmissionNew England Journal of Medicine, 2008
- SAVVY Vaginal Gel (C31G) for Prevention of HIV Infection: A Randomized Controlled Trial in NigeriaPLOS ONE, 2008
- Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trialThe Lancet, 2007
- Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trialThe Lancet, 2007
- The Potential Impact of Male Circumcision on HIV in Sub-Saharan AfricaPLoS Medicine, 2006
- Overview of effective and promising interventions to prevent HIV infection.2006
- Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trialThe Lancet, 2002
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976
- Repeated assessment of results in clinical trials of cancer treatmentThe British Journal of Radiology, 1971